469 related articles for article (PubMed ID: 11776303)
1. Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy.
Pauzner R; Dulitzki M; Langevitz P; Livneh A; Kenett R; Many A
Thromb Haemost; 2001 Dec; 86(6):1379-84. PubMed ID: 11776303
[TBL] [Abstract][Full Text] [Related]
2. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin.
Brenner B; Hoffman R; Blumenfeld Z; Weiner Z; Younis JS
Thromb Haemost; 2000 May; 83(5):693-7. PubMed ID: 10823264
[TBL] [Abstract][Full Text] [Related]
3. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
Sarasin FP; Bounameaux H
Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
[TBL] [Abstract][Full Text] [Related]
4. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin.
McLintock C; McCowan LM; North RA
BJOG; 2009 Nov; 116(12):1585-92. PubMed ID: 19681850
[TBL] [Abstract][Full Text] [Related]
5. Prevention of thrombosis during pregnancy.
Vilela VS; de Jesús NR; Levy RA
Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
[No Abstract] [Full Text] [Related]
6. [Warfarin in the treatment of antiphospholipid syndrome].
Reshetniak TM; Kondrat'eva LV; Patrusheva NL; Patrushev LI
Ter Arkh; 2007; 79(5):47-54. PubMed ID: 17672075
[TBL] [Abstract][Full Text] [Related]
7. Successful pregnancy outcome with combination therapy in women with the antiphospholipid antibody syndrome.
Menashe Y; Ben-Baruch G; Greenspoon JS; Carp HJ; Rosen DJ; Mashiach S; Many A
J Reprod Med; 1993 Aug; 38(8):625-9. PubMed ID: 8410869
[TBL] [Abstract][Full Text] [Related]
8. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J
Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498
[TBL] [Abstract][Full Text] [Related]
9. Enoxaparin versus unfractionated heparin in the management of recurrent abortion secondary to antiphospholipid syndrome.
Fouda UM; Sayed AM; Abdou AM; Ramadan DI; Fouda IM; Zaki MM
Int J Gynaecol Obstet; 2011 Mar; 112(3):211-5. PubMed ID: 21251653
[TBL] [Abstract][Full Text] [Related]
10. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy.
Narin C; Reyhanoglu H; Tülek B; Onoglu R; Ege E; Sarigül A; Yeniterzi M; Durmaz I
Adv Ther; 2008 Jun; 25(6):585-94. PubMed ID: 18568442
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome in systemic lupus erythematosus complicated by anti-phospholipid antibodies.
Mecacci F; Bianchi B; Pieralli A; Mangani B; Moretti A; Cioni R; Giorgi L; Mello G; Matucci-Cerinic M
Rheumatology (Oxford); 2009 Mar; 48(3):246-9. PubMed ID: 19109318
[TBL] [Abstract][Full Text] [Related]
12. Aspirin, warfarin, or enoxaparin thromboprophylaxis in patients with multiple myeloma treated with thalidomide: a phase III, open-label, randomized trial.
Palumbo A; Cavo M; Bringhen S; Zamagni E; Romano A; Patriarca F; Rossi D; Gentilini F; Crippa C; Galli M; Nozzoli C; Ria R; Marasca R; Montefusco V; Baldini L; Elice F; Callea V; Pulini S; Carella AM; Zambello R; Benevolo G; Magarotto V; Tacchetti P; Pescosta N; Cellini C; Polloni C; Evangelista A; Caravita T; Morabito F; Offidani M; Tosi P; Boccadoro M
J Clin Oncol; 2011 Mar; 29(8):986-93. PubMed ID: 21282540
[TBL] [Abstract][Full Text] [Related]
13. The management of thrombosis in the antiphospholipid-antibody syndrome.
Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR
N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428
[TBL] [Abstract][Full Text] [Related]
14. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial.
Pattison NS; Chamley LW; Birdsall M; Zanderigo AM; Liddell HS; McDougall J
Am J Obstet Gynecol; 2000 Oct; 183(4):1008-12. PubMed ID: 11035355
[TBL] [Abstract][Full Text] [Related]
15. Prosthetic heart valves and pregnancy.
McLintock C; North RA; White HD
Circulation; 2003 Dec; 108(23):e159-60; author reply e159-60. PubMed ID: 14662695
[No Abstract] [Full Text] [Related]
16. Management of antiphospholipid syndrome.
Tuthill JI; Khamashta MA
J Autoimmun; 2009 Sep; 33(2):92-8. PubMed ID: 19559568
[TBL] [Abstract][Full Text] [Related]
17. The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women.
Le Thi Thuong D; Tieulié N; Costedoat N; Andreu MR; Wechsler B; Vauthier-Brouzes D; Aumaître O; Piette JC
Ann Rheum Dis; 2005 Feb; 64(2):273-8. PubMed ID: 15647435
[TBL] [Abstract][Full Text] [Related]
18. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience.
Branch DW; Silver RM; Blackwell JL; Reading JC; Scott JR
Obstet Gynecol; 1992 Oct; 80(4):614-20. PubMed ID: 1407882
[TBL] [Abstract][Full Text] [Related]
19. The Italian Registry of Antiphospholipid Antibodies.
Finazzi G
Haematologica; 1997; 82(1):101-5. PubMed ID: 9107095
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome.
Fouda UM; Sayed AM; Ramadan DI; Fouda IM
J Obstet Gynaecol; 2010; 30(8):842-6. PubMed ID: 21126127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
